CURALEAF ranks #34 in the Flower category, trailing market leaders like ABUNDANT ORGANICS and JUST FLOWER by significant margins. The brand has lost 22 spots to ABUNDANT ORGANICS and 18 to JUST FLOWER, underscoring a competitive gap that needs addressing.
SKU View
Top Selling ProductsJun 2026
Top products for Jun 2026 with sales and momentum indicators.
Our mission is to help our patients to Live Life Well. Curaleaf offers high-quality, affordable and consistent medical cannabis products in a continually growing variety of forms including tinctures, vape cartridges, capsules, micro-tablets and ground flower.
CURALEAF's growth has collapsed with a staggering YoY decline of 65.5%. The brand's rank has slipped from #12 to #34, reflecting a troubling trend in market presence. Recent months show a 41.4% drop, emphasizing the urgent need for strategic reevaluation.
Flower dominates at 45.6%, yet has plummeted 74.1% YoY. Concentrates hold 22.8% with a 35.1% decline, while Pre-Rolls at 11.2% have fallen 66.3%. Vapes and Edibles also struggle, showcasing a broader category contraction.
Category
Sales Share
Avg Price
YoY
Flower
48.6%
$35.16
30.9%
Concentrates
21.3%
$23.51
26.7%
Pre-Rolls
11.8%
$5.56
66.1%
Vapes
8.6%
$15.49
57.3%
Oral
6.3%
$25.36
13.6%
Edibles
2.5%
$26.26
70.8%
Trend View
Market Insights SnapshotJun 2026
24-Month Trend
Average Price
$18.31
YoY Sales Trend
41.9%
2Y Sales Trend
76.6%
Category Breakout
Category
Sales Share
Avg Price
YoY
Flower
48.6%
$35.16
30.9%
Concentrates
21.3%
$23.51
26.7%
Pre-Rolls
11.8%
$5.56
66.1%
Vapes
8.6%
$15.49
57.3%
Oral
6.3%
State Rank Table
State
Flower
Concentrates
Pre-Roll
Vapes
Oral
Edibles
New York
⊖
⊖
⊖
⊖
9
⊖
Arizona
16
⊖
⊖
⊖
⊖
⊖
Connecticut
14
⊖
19
CURALEAF's footprint spans four states, with a stronghold in Florida (43.8%) and notable shares in Connecticut (29.2%) and Arizona (24.6%). This geographic concentration highlights potential growth areas amidst overall brand challenges.
Curaleaf Top StatesJun 2026
